Showing 1691-1700 of 3041 results for "".
- Jan Marini Launches New Peel Systemhttps://practicaldermatology.com/news/20130206-jan_marini_launches_new_peel_system/2459619/Jan Marini Skin Research launched the Marini Peel Systems, which combine peels with concentrated retinol, peptides, and antioxidants for individuals seeking more aggressive treatments for issues ranging from sun damage to skin coloration. The systems include the Refine Peel, for skin rejuvenation, t
- Allergan, Inc. to Acquire MAP Pharmaceuticals, Inc.https://practicaldermatology.com/news/20130123-allergan_inc_to_acquire_map_pharmaceuticals_inc/2459632/Allergan, Inc. and MAP Pharmaceuticals, Inc. entered into a definitive merger agreement whereby Allergan will acquire 100 percent of the shares of MAP Pharmaceuticals for a price of $25.00 pe
- Jan Marini Skin Research Launches Regeneration Boosterhttps://practicaldermatology.com/news/20130110-jan_marini_skin_research_launches_regeneration_booster/2459643/Jan Marini Skin Research released its all-new Regeneration Booster. Cycloastragenol, TGF Beta-1, multiple beneficial growth factors, and four advanced anti-aging peptides are combined with coenzyme Q10 and additional antioxidants to reduce the a
- Valeant Pharmaceuticals Appoints New Managementhttps://practicaldermatology.com/news/20130103-valeant_pharmaceuticals_appoints_new_management/2459649/Valeant Pharmaceuticals International, Inc. named Laizer D. Kornwasser the Executive Vice President/Company Group Chairman, where he will be responsible for operations in Canada, US Neurology, and managed care and distribution, effective February
- North American Facial Injectable Market to Hit $1.7 Billion by 2017https://practicaldermatology.com/news/20121228-north_american_facial_injectable_market_to_hit_17_billion_by_2017/2459652/According to Millennium Research Group, the North American facial injectables market, comprising botulinum toxin and dermal fillers sold in the US and Canada, will continue to show strong growth for the next five years, reaching a total value of more
- Murad Names Suzanne Dawson Chief Marketing Officerhttps://practicaldermatology.com/news/20121213-murad_names_suzanne_dawson_chief_marketing_officer/2459658/Murad Inc. named Suzanne Dawson Chief Marketing Officer, overseeing all global marketing including brand development, advertising, public relations, creative, and education, for products, services, and new market opportunities. Dawson comes to Murad
- The Medical Entrepreneur Symposium Adds New Session for Office Managershttps://practicaldermatology.com/news/20121017-the_medical_entrepreneur_symposium_adds_new_session_for_office_managers/2459702/The Medical Entrepreneur Symposium, a unique educational meeting for physicians, their office managers and executives in healthcare, has added an office manager focused breakout session called "Be A Better Office Manager." The symposium is based on the popularity of Dr. Steven Hacker's top-selling p
- Veil Cosmetics Introduced to Markethttps://practicaldermatology.com/news/20120727-veil_cosmetics_introduced_to_market/2459761/The concept of makeup artist Sébastien Tardif, Veil Cosmetics was inspired by Tardif's foundation in both art and fashion, which inspired the palette of bright-based colors that lift and illuminate the skin. Tardif cultivated his skincare sensibilities during his tenure in Asia, which led him
- Data Suggest Makucell's Asymmtate Reverses Gene Expression in Aging Skinhttps://practicaldermatology.com/news/20120725-makucell_announces_results_on_proprietary_technology_asymmtate/2459765/Makucell, Inc.'s Asymmtate(TM), the key ingredient in the Renewnt line, may reverse gene expression changes associated with aging skin and with lentigines. Findings for Asymmtate, a proprietary cosmetic ingredient that influences the gene co-act
- Alcohol May Influence Skin Cancer Riskhttps://practicaldermatology.com/news/20120720-alcohol_may_influence_skin_cancer_risk/2459766/Evidence suggests that alcohol consumption may have some influence on risk for developing BCC but not SCC. (J Invest Dermatol. E-pub) Consumption of wine and spirits, specifically, appears to increase BCC risk, while beer consumption does not. Results come from an analysis of data on 54,766 people e